A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2007
12/20/2007	US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007	US20070292427 Substantially pure steroidogenesis inducing peptide and uses thereof
12/20/2007	US20070292426 Methods and compositions based on Shiga toxin type 1 protein
12/20/2007	US20070292424 Novel human eosinophil-derived basic protein
12/20/2007	US20070292419 Treatment with anti-erbb2 antibodies
12/20/2007	US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance
12/20/2007	US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer
12/20/2007	US20070292414 Compositions enriched in neoplastic stem cells and methods comprising same
12/20/2007	US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances
12/20/2007	US20070292412 Novel genes and markers in type 2 diabetes and obesity
12/20/2007	US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders
12/20/2007	US20070292408 compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene
12/20/2007	US20070292407 Methods of treatment for meconium aspiration syndrome
12/20/2007	US20070292406 Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restenosis using said composition
12/20/2007	US20070292405 Uses of Erss Modulators
12/20/2007	US20070292404 Antimicrobial polymer conjugates
12/20/2007	US20070292403 Methods of treating a neurological disorder with creatine monohydrate
12/20/2007	US20070292396 Combination therapy with oncolytic adenovirus
12/20/2007	US20070292393 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/20/2007	US20070292392 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/20/2007	US20070292391 formulations of interferon-beta comprising a buffer, an amino acid and an antioxidant; comprising interferon-beta 1a, lysine, methionine, poloxomer 188 and an aqueous acetate buffer
12/20/2007	US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies
12/20/2007	US20070292389 Method for the Purification and Amplification of Tumoral Stem Cells
12/20/2007	US20070292387 Transmucosal delivery of pharmaceutical active substances
12/20/2007	US20070292386 Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
12/20/2007	US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/20/2007	US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6
12/20/2007	US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases
12/20/2007	CA2602555A1 Composition and method for reducing inflammation
12/19/2007	EP1867996A1 Kit for determining HGF in excrement
12/19/2007	EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007	EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
12/19/2007	EP1867719A2 Methods and compositions for inhibiting neoplastic cell growth
12/19/2007	EP1867718A2 Therapeutically useful synthetic oligonucleotides
12/19/2007	EP1867717A1 Method of ameliorating symptom caused by mood disturbance
12/19/2007	EP1867658A1 Lactalbumin production process
12/19/2007	EP1867340A1 Therapeutic agent for bovine digestive system disease
12/19/2007	EP1867339A1 Anti-viral agent
12/19/2007	EP1867338A1 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases
12/19/2007	EP1866441A2 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
12/19/2007	EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins
12/19/2007	EP1866334A1 Inhibitor of endogenous human interferon - gamma
12/19/2007	EP1866332A1 Use of crotamine, kit and composition
12/19/2007	EP1865982A1 Hydrogel composition for modulation of topical inflammatory response
12/19/2007	EP1865981A2 Cacna1e in cancer diagnosis, detection and treatment
12/19/2007	EP1865980A2 Abuse-resistant amphetamine prodrugs
12/19/2007	EP1865979A2 Treatment of cognitive and learning impairment
12/19/2007	EP1865978A2 New neuronal pain pathway
12/19/2007	EP1865976A1 Use of natriuretic peptide for treating heart failure
12/19/2007	EP1865934A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
12/19/2007	EP1865773A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
12/19/2007	EP1578366A4 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
12/19/2007	EP1558278A4 Production of homotrimeric fusion proteins
12/19/2007	EP1503757B1 Tyrosine kinase inhibitors
12/19/2007	EP1487285B1 Alertness bar
12/19/2007	EP1416965B1 Assay method for alzheimer's disease
12/19/2007	EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses
12/19/2007	EP1303599B1 Methylated nucleotide regulation of upa gene expression
12/19/2007	EP1230369B1 Polypeptide hormone phosphatonin
12/19/2007	EP1229927B1 Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety
12/19/2007	EP1204427A4 The nasal transmucosal delivery of peptides conjugated with biocompatible polymers
12/19/2007	EP1194033B1 Transgenically produced antithrombin iii and mutants thereof
12/19/2007	EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007	EP1091757B1 Alpha emitting constructs and uses thereof
12/19/2007	EP0954578B1 Glycoprotein hormone (tsh) superagonists
12/19/2007	EP0934337B1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
12/19/2007	EP0772689B1 Retroviral vectors having a reduced recombination rate
12/19/2007	EP0652950B1 Generation of xenogeneic antibodies
12/19/2007	EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
12/19/2007	CN101090980A 经修饰的人类生长激素 Modified human growth hormone
12/19/2007	CN101090977A Tripeptide and tetrapeptide thioethers
12/19/2007	CN101090912A Torc polynucleotides and polypeptides, and methods of use
12/19/2007	CN101090910A Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery
12/19/2007	CN101090909A Antibacterial amide macrocycles IV
12/19/2007	CN101090732A Method for treating diabetes
12/19/2007	CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
12/19/2007	CN101090730A Composition and method for increasing apoptosis in cancer cells
12/19/2007	CN101090729A Antibodies and related molecules that bind to psca proteins
12/19/2007	CN101090726A Cladribine regimen for treating multiple sclerosis
12/19/2007	CN101089180A Recombination LFA3 gene, and its mixed gene and product
12/19/2007	CN101089179A Hog B-lymphocyte irritation factor CDNA and its clone method and recombination application
12/19/2007	CN101089178A Beta-lactamase and its prepn process and application
12/19/2007	CN101089019A Polypeptides with antithrombotic activity and their prepn process and application
12/19/2007	CN101089018A Woodfrog egg protein with anticancer function and its prepn process
12/19/2007	CN101089014A Synthesis mode and the use of its product
12/19/2007	CN101088558A Effervescent tablet of human interferon-alpha-2b and its prepn process
12/19/2007	CN101088557A Medicine composition for preventing and treating HIV infection and its application
12/19/2007	CN100355884C Novel earthworm fibrinolytic enzyme, its encoding sequence and uses
12/19/2007	CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives
12/19/2007	CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b
12/19/2007	CN100355782C New liver cancer up expressing gene and its encoded protein and application
12/19/2007	CN100355781C 肽 Peptide
12/19/2007	CN100355776C Novel alpha-melanocyte stimulating hormone analogue and use thereof
12/19/2007	CN100355453C Improved vaccines
12/19/2007	CN100355452C Carbonyl stress-ameliorating agents
12/18/2007	USRE39941 Amelioration of Dupuytren's disease
12/18/2007	US7309814 Nucleic acid molecules encoding bacterial autoinducer inactivation protein as targets for engineering disease resistance
12/18/2007	US7309786 Dna sequences, Rna sequences; binding to tumor necrosis factor
12/18/2007	US7309780 Antibodies to natural killer cell activating factor II
12/18/2007	US7309779 Male reproductive disorders including proliferative disorders of testes

1 ... 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 ... 3163